eslicarbazepine acetate has been researched along with veratrine in 1 studies
| Studies (eslicarbazepine acetate) | Trials (eslicarbazepine acetate) | Recent Studies (post-2010) (eslicarbazepine acetate) | Studies (veratrine) | Trials (veratrine) | Recent Studies (post-2010) (veratrine) |
|---|---|---|---|---|---|
| 229 | 68 | 175 | 808 | 1 | 16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parada, A; Soares-da-Silva, P | 1 |
1 other study(ies) available for eslicarbazepine acetate and veratrine
| Article | Year |
|---|---|
The novel anticonvulsant BIA 2-093 inhibits transmitter release during opening of voltage-gated sodium channels: a comparison with carbamazepine and oxcarbazepine.
Topics: Animals; Anticonvulsants; Carbamazepine; Corpus Striatum; Dibenzazepines; Electrophysiology; In Vitro Techniques; Ion Channel Gating; Male; Neurotransmitter Agents; Oxcarbazepine; Rats; Rats, Wistar; Sodium Channels; Veratrine | 2002 |